100.36 Ischemic Versus Bleeding Risk Consideration for the Duration of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions

Patients undergoing percutaneous coronary intervention (PCI) often have clinical risk factors that predispose them to both ischemic events and increased bleeding. Dual antiplatelet therapy (DAPT) is required for PCI but does heighten the risk of bleeding. This study aimed to determine whether the